NervGen Pharma
A medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
€118m
Enterprise valuation
€101m (Public information from Sep 2024)
Share price
$2 NGENF
Vancouver British Columbia (HQ)
Authorizing premium user...